Last reviewed · How we verify
Banxiaxiexin decoction
Banxiaxiexin decoction is a traditional Chinese medicine formulation that modulates inflammatory and immune responses to treat respiratory and gastrointestinal conditions.
Banxiaxiexin decoction is a traditional Chinese medicine formulation that modulates inflammatory and immune responses to treat respiratory and gastrointestinal conditions. Used for Respiratory tract infections with phlegm accumulation, Chronic bronchitis or related inflammatory airway conditions.
At a glance
| Generic name | Banxiaxiexin decoction |
|---|---|
| Sponsor | Nanjing First Hospital, Nanjing Medical University |
| Drug class | Traditional Chinese medicine herbal decoction |
| Modality | Small molecule |
| Therapeutic area | Respiratory/Gastrointestinal |
| Phase | Phase 3 |
Mechanism of action
As a herbal decoction, Banxiaxiexin combines multiple botanical ingredients traditionally used in Chinese medicine to reduce inflammation, clear phlegm, and regulate immune function. The formulation is believed to work through multiple pathways rather than a single molecular target, consistent with traditional Chinese medicine principles of multi-component synergistic action.
Approved indications
- Respiratory tract infections with phlegm accumulation
- Chronic bronchitis or related inflammatory airway conditions
Common side effects
Key clinical trials
- Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Banxiaxiexin decoction CI brief — competitive landscape report
- Banxiaxiexin decoction updates RSS · CI watch RSS
- Nanjing First Hospital, Nanjing Medical University portfolio CI